November 17 2009 Issue

This Podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Interim Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Michelle Mauermann interview Dr. Hiroshi Mitsumoto about his paper on how progressive muscular atrophy is a form of ALS. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about neuromuscular disorders unmasked by statin therapy. The podcast concludes where Dr. Beau Bruce interviews Dr. Brian Weinshenker for the Lesson of the Week (disease of the month) on neuromyelitis optica. The participants had nothing to disclose except Drs. Mitsumoto & Weinshenker. Dr. Mitsumoto has served on scientific advisory boards for and/or received speaker honoraria from Avanir Pharmaceuticals, Knopp Neurosciences Inc., Neuralstem, Inc., and Sanofi-aventis, and Otsuka Pharmaceutical Co., Ltd.; and has received research support from Avanir Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Knopp Neurosciences Inc., the NIH [NINDS #R01NS04812 (Co-I) and NIEHS #1R01ES016348-01A2 (PI)], the Muscular Dystrophy Association, the ALS Association, and the MDA Wings Over Wall Street.Dr. Weinshenker serves as an editorial board members for Canadian Journal of Neurosciences and Turkish Journal of Neurology, received revenue for a patent held by Mayo Foundation licensed to RSR Limited, was a consultant for CaridianBCT in 2008, and receives research support from the Guthy-Jackson Charitable Foundation.